Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bacigalupo, Andrea
Bigeminy, NCT04166929: Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS	Terminated	2	6	Europe	Haplo SCT with NK cells, haplo SCT followed by NK cell infusion, Haplo SCT, Standard haplo SCT without subsequent NK cell boost.	Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Ministry of Health, Italy	Acute Myeloid Leukemia, Myelodysplasia	09/23	09/23
NCT04709458: Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis	Not yet recruiting	1	10	Europe, RoW	TBX-2400	Taiga Biotechnologies, Inc.	Myelofibrosis, Acute Myelogenous Leukemia	08/24	10/24
COmPACt, NCT03802773: Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide ( Study)	Recruiting	N/A	10	Europe	CB transplantation, Myeloablative conditioning and post-transplant cyclophosphamide	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Cord Blood Transplantation, Hematological Malignancies	01/23	12/23